Sources | Names Used |
---|---|
CTRPv2 | BRD-K64610608 |
PharmacoGx | BRD-K64610608 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OPN1SW | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
mRNA | PTTG1IP | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
mRNA | MYO10 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
mRNA | RABGEF1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | MYO9B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
mRNA | ANKS6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | GTF2IRD1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
mRNA | C2orf74 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | FBLIM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |